Myocardial Reperfusion Injury

The immediate cause is reperfusion of ischemic myocardium. The supplied grounding does not support a broader etiologic explanation beyond restoration of blood flow after ischemia.

Reperfusion can itself trigger cardiomyocyte death through mechanisms involving apoptosis, cell death signaling, oxidative stress, inflammatory activation, and mitochondrial dysfunction. The grounding also supports endoplasmic reticulum stress and the unfolded protein response as contributors to cell death in ischemia/reperfusion injury, along with defects in mitophagy and mitochondrial permeability transition. These processes are linked to signal transduction changes and injury across multiple cardiac cell types.

The main risk context is acute myocardial infarction treated with reperfusion, including thrombolytic therapy or primary percutaneous coronary intervention. The grounding does not support additional patient-level risk factors.

The general treatment approach is timely myocardial reperfusion for acute myocardial infarction, using thrombolytic therapy or primary percutaneous coronary intervention. The supplied reviews indicate that reperfusion injury itself has no established effective therapy, although multiple investigational strategies are under study to prevent it. At the modality level, management centers on reperfusion-based revascularization rather than a specific approved drug class for reperfusion injury.